文献速递复苏、休克与脓毒症创伤与烧伤

REBOA在濒临创伤性心脏骤停患者中的可行性与临床结局

Feasibility and Clinical Outcome of Reboa in Patients with Impending Traumatic Cardiac Arrest.
PubMed 文献 · Shock · 2020-01-01
一句话结论在濒临创伤性心脏骤停患者中,REBOA置入并充盈后收缩压显著改善至90 mmHg,36.6%的患者存活。

本研究利用ABOTrauma注册研究的数据,回顾性和前瞻性收集了全球16个中心收治的74例濒临创伤性心脏骤停(ITCA)患者,所有患者均尝试了REBOA。结果显示,66.7%使用7-10Fr导管,58.5%首次尝试即置入成功,52.1%为盲插,93.2%在I区充盈,64.8%充盈时间为30-60分钟,82.1%由急诊医生、创伤外科医生或血管外科医生操作。REBOA充盈后收缩压显著改善至90 mmHg,36.6%的患者存活。作者结论认为,在ITCA患者中REBOA可能可行,若置入成功可提升收缩压并使36.6%的患者存活。

要点

  • 在74例濒临创伤性心脏骤停患者中,REBOA充盈后收缩压显著改善至90 mmHg。
  • 36.6%的濒临创伤性心脏骤停患者在接受REBOA后存活。
  • 93.2%的REBOA在I区充盈,64.8%的充盈持续时间为30至60分钟。
  • 58.5%的REBOA首次尝试即置入成功,52.1%通过盲插完成。
  • 82.1%的REBOA由急诊医生、创伤外科医生或血管外科医生操作。

适用人群与场景

  • 来自ABOTrauma注册研究的濒临创伤性心脏骤停(ITCA)患者,共74例,全球16个中心收治。

处置流程与药物剂量

  • REBOA使用7-10Fr导管(66.7%),58.5%首次尝试置入成功,52.1%为盲插。
  • 93.2%的REBOA在I区充盈,64.8%的充盈持续时间为30至60分钟。
  • 82.1%的操作由急诊医生、创伤外科医生或血管外科医生完成。

研究设计与关键结果

  • 研究类型为基于ABOTrauma注册研究的回顾性和前瞻性数据收集,纳入全球16个中心的74例濒临创伤性心脏骤停患者。
  • 所有患者均行REBOA,66.7%使用7-10Fr导管,58.5%首次尝试置入成功,52.1%为盲插,93.2%在I区充盈,64.8%充盈时间为30至60分钟,82.1%由急诊医生、创伤外科医生或血管外科医生操作。
  • REBOA充盈后收缩压显著改善至90 mmHg。
  • 36.6%的患者存活。

证据类型、等级与局限

  • 证据类型:基于注册研究的回顾性和前瞻性数据收集。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在濒临创伤性心脏骤停患者中REBOA可能可行,若置入成功可提升收缩压并使36.6%的患者存活。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) may improve Systolic Blood Pressure (SBP) in hypovolemic shock. It has, however, not been studied in patients with impending traumatic cardiac arrest (ITCA). We aimed to study the feasibility and clinical outcome of REBOA in patients with ITCA using data from the ABOTrauma Registry.

METHODS: Retrospective and prospective data on the use of REBOA from 16 centers globally were collected. SBP was measured both at pre- and post-REBOA inflation. Data collected included patients' demography, vascular access technique, number of attempts, catheter size, operator, zone and duration of occlusion, and clinical outcome.

RESULTS: There were 74 patients in this high-risk patient group. REBOA was performed on all patients. A 7-10Fr catheter was used in 66.7% and 58.5% were placed on the first attempt, 52.1% through blind insertion and 93.2% inflated in Zone I, 64.8% for a period of 30 to 60 min, 82.1% by ER doctors, trauma surgeons, or vascular surgeons. SBP significantly improved to 90 mm Hg following the inflation of REBOA. 36.6% of the patients survived.

CONCLUSIONS: Our study has shown that REBOA may be performed in patients with ITCA, SBP can be elevated, and 36.6% of the patients survived if REBOA placement is successful.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. McGreevy DT, Abu-Zidan FM, Sadeghi M, et al. Feasibility and Clinical Outcome of Reboa in Patients with Impending Traumatic Cardiac Arrest. Shock. 2020. PMID: 31851119. doi:10.1097/SHK.0000000000001500

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。